Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Friday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Friday. The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.01. The company has a market cap of $2,383.50, a price-to-earnings ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $1.99.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.